Global Pharmaceutical Contract Manufacturing & Research Services Market 2021
![](/report_cover/11753/global-pharmaceutical-contract-manufacturing-research-services-market-2021_en.gif)
According to a report by StrategyHelix, the global pharmaceutical contract manufacturing & research services market is set to increase by US$ 49,632 million during 2021-2027, growing at a CAGR of 4.8% during the forecast period. Increasing R&D investment, favorable government intervention, increase in pharmaceutical outsourcing practices are expected to boost the market growth in the coming years.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for pharmaceutical contract manufacturing & research services. The global pharmaceutical contract manufacturing & research services market is segmented on the basis of service type, applications, and region. On the basis of service type, the global pharmaceutical contract manufacturing & research services market has been segmented into manufacturing, packaging, research. Manufacturing was the highest contributor to the global pharmaceutical contract manufacturing & research services market. Going forward, the research segment is projected to witness the highest CAGR during the forecast period. By applications, the global pharmaceutical contract manufacturing & research services market has been segmented into cardiovascular, oncology, antibiotics, analgesics, antivirals, others. Geographically, the global pharmaceutical contract manufacturing & research services market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).
The global pharmaceutical contract manufacturing & research services market is highly competitive. The leading players in the pharmaceutical contract manufacturing & research services market include AbbVie Inc., Amcor Ltd., AMRI (Albany Molecular Research Inc.), Delpharm SAS, Eurofins Scientific SE, Fareva Group, Lonza Group AG, Patheon N.V., Pfizer CentreOne, Recipharm AB, Siegfried AG.
Report Scope
Service type: manufacturing, packaging, research
Applications: cardiovascular, oncology, antibiotics, analgesics, antivirals, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global pharmaceutical contract manufacturing & research services market
Pinpoint growth sectors and trends for investment
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for pharmaceutical contract manufacturing & research services. The global pharmaceutical contract manufacturing & research services market is segmented on the basis of service type, applications, and region. On the basis of service type, the global pharmaceutical contract manufacturing & research services market has been segmented into manufacturing, packaging, research. Manufacturing was the highest contributor to the global pharmaceutical contract manufacturing & research services market. Going forward, the research segment is projected to witness the highest CAGR during the forecast period. By applications, the global pharmaceutical contract manufacturing & research services market has been segmented into cardiovascular, oncology, antibiotics, analgesics, antivirals, others. Geographically, the global pharmaceutical contract manufacturing & research services market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).
The global pharmaceutical contract manufacturing & research services market is highly competitive. The leading players in the pharmaceutical contract manufacturing & research services market include AbbVie Inc., Amcor Ltd., AMRI (Albany Molecular Research Inc.), Delpharm SAS, Eurofins Scientific SE, Fareva Group, Lonza Group AG, Patheon N.V., Pfizer CentreOne, Recipharm AB, Siegfried AG.
Report Scope
Service type: manufacturing, packaging, research
Applications: cardiovascular, oncology, antibiotics, analgesics, antivirals, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global pharmaceutical contract manufacturing & research services market
Pinpoint growth sectors and trends for investment
PART 1. INTRODUCTION
Scope of the study
Study period
Geographical scope
Research methodology
PART 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET OVERVIEW
PART 3. MARKET BREAKDOWN BY SERVICE TYPE
Manufacturing
Packaging
Research
PART 4. MARKET BREAKDOWN BY APPLICATIONS
Cardiovascular
Oncology
Antibiotics
Analgesics
Antivirals
Others
PART 5. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 6. KEY COMPANIES
AbbVie Inc.
Amcor Ltd.
AMRI (Albany Molecular Research Inc.)
Delpharm SAS
Eurofins Scientific SE
Fareva Group
Lonza Group AG
Patheon N.V.
Pfizer CentreOne
Recipharm AB
Siegfried AG
About StrategyHelix
Disclaimer
Scope of the study
Study period
Geographical scope
Research methodology
PART 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET OVERVIEW
PART 3. MARKET BREAKDOWN BY SERVICE TYPE
Manufacturing
Packaging
Research
PART 4. MARKET BREAKDOWN BY APPLICATIONS
Cardiovascular
Oncology
Antibiotics
Analgesics
Antivirals
Others
PART 5. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 6. KEY COMPANIES
AbbVie Inc.
Amcor Ltd.
AMRI (Albany Molecular Research Inc.)
Delpharm SAS
Eurofins Scientific SE
Fareva Group
Lonza Group AG
Patheon N.V.
Pfizer CentreOne
Recipharm AB
Siegfried AG
About StrategyHelix
Disclaimer